Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
77,514.79
(
-0.14%
)
News Focus
News Focus
Post# of 257443
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

vinmantoo

Send PM Follow Ignore
Followers 28
Posts 4696
Boards Moderated 0
Alias Born 07/25/2007

vinmantoo

Re: willyw post# 251662

Wednesday, 05/01/2024 2:55:30 PM

Wednesday, May 01, 2024 2:55:30 PM

Post# of 257443

4) Somewhat unrelated, if it were such that Enanta's patent was upheld in court might that also serve to encourage a potential phase 3 trial collaboration?



Keep in mind that ENTA is suing PFE because they claim that Paxlovid violated one of ENTA's patents. ENTA's anti-Covid drug EDP-235 is not part of this patent dispute but is a different compound.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today